Literature DB >> 21727691

Pemphigus in India.

Amrinder J Kanwar1, Dipankar De.   

Abstract

Pemphigus is a chronic epidermal immunobullous disease with potentially fatal outcome. The journey of literature on pemphigus in India has come a long way in last five decades. Pemphigus in Indian patients has unique genetic, clinical, and epidemiological differences from those in the Western countries. Corticosteroids remain the mainstay of treatment for pemphigus. Dexamethasone-cyclophosphamide pulse therapy has revolutionized the management of pemphigus in India and abroad for nearly 3 decades now. Corticosteroid-based treatment, along with adjuvants, has significantly brought down the high mortality rates that had been observed in precorticosteroid era. Present day research is largely based on elucidating the pathogenesis beyond the antidesmoglein antibodies, and newer diagnostic and treatment approaches. In this article, we review various aspects of literature on pemphigus in India, on Indians abroad, or literature from other countries that are considered relevant to the topic.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21727691     DOI: 10.4103/0378-6323.82396

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  16 in total

1.  Pemphigus vulgaris--a report of three cases.

Authors:  Harshkant P Gharote; Preeti P Nair; Sowmya Kasetty; Shaji Thomas; Abhay Kulkarni
Journal:  BMJ Case Rep       Date:  2012-03-08

2.  Rituximab: A Magic Bullet for Pemphigus.

Authors:  V Anandan; W Afthab Jameela; R Sowmiya; M Mani Surya Kumar; P Lavanya
Journal:  J Clin Diagn Res       Date:  2017-04-01

3.  A Cross-sectional Study of Clinical, Histopathological and Direct Immunofluorescence Spectrum of Vesiculobullous Disorders.

Authors:  Arundhathi S; Ragunatha S; Mahadeva K C
Journal:  J Clin Diagn Res       Date:  2013-12-15

4.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123

Review 5.  Stem cell therapy: A novel treatment approach for oral mucosal lesions.

Authors:  G N Suma; Madhu Pruthi Arora; Manisha Lakhanpal
Journal:  J Pharm Bioallied Sci       Date:  2015 Jan-Mar

6.  Vitamin D deficiency and lower TGF-β/IL-17 ratio in a North Indian cohort of pemphigus vulgaris.

Authors:  Neha Joshi; Ranjana W Minz; Shashi Anand; Nisha V Parmar; Amrinder J Kanwar
Journal:  BMC Res Notes       Date:  2014-08-15

7.  Pemphigus vulgaris in an elderly patient.

Authors:  Milind A Patvekar; Dinkar Sadana
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

Review 8.  Eponymous dermatological signs in bullous dermatoses.

Authors:  Sentamilselvi Ganapati
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

9.  Pulse Therapy in Pemphigus: Ready Reckoner.

Authors:  Anil Abraham; Gillian Roga; Anupa Mary Job
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

10.  A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris.

Authors:  Sudip Das; Komal Agarwal; Sonal Singh; Deepika Halder; Sujata Sinha; Abhishek De
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.